Limited Period Offer: Get up to 10% off + extra 15% off on medicines & more offers. Explore
(0) Write a review
In stock

Mysimba (Naltrexone / Bupropion) Weight Loss Tablets

Zakres cen: od €99.99 do €195.99

55 people are viewing this right now
  • Weight loss tablets
  • Helps reduce food cravings
  • For those with a BMI of 30 or over
  • Always read the patient information leaflet before use
Buy now
  • Free Shipping Icon SVG Vector & PNG Free Download | UXWingFree Shipping & Returns on this item
  • Delivery within 3-5 working days
  • Money Back Guarantee

Description

Mysimba: The Oral Tablet Alternative for Weight Loss

Mysimba is the leading oral weight loss tablet licensed in Europe — a once-daily pill that combines two well-established medications: naltrexone and bupropion. For patients who prefer not to inject, can’t tolerate GLP-1 medications, or have specific medical reasons to avoid them, Mysimba offers a clinically-validated alternative with average weight loss of 5–9% over 56 weeks in trials. EU Slim Store offers Mysimba prescribed by Dutch BIG-registered doctors after a free online consultation.

How Mysimba Works — A Different Mechanism Entirely

Unlike GLP-1 medications, which mimic gut hormones, Mysimba targets the brain’s hunger and reward systems directly. The two active ingredients work together:

  • Naltrexone — an opioid receptor antagonist that disrupts the reward response your brain gets from food, especially high-fat and high-sugar foods
  • Bupropion — a noradrenaline and dopamine reuptake inhibitor that increases satiety signals and reduces food-focused thoughts

Together, the combination targets both the want (reward) and need (hunger) drivers of overeating. This is fundamentally different from GLP-1 medications, which target gut hormones and stomach emptying.

Who Should Consider Mysimba?

Mysimba is licensed for adults with:

  • BMI ≥ 30 (obesity), or
  • BMI ≥ 27 with at least one weight-related condition (type 2 diabetes, dyslipidaemia, hypertension)

Mysimba may be particularly appropriate for patients who:

  • Prefer tablets over injections
  • Are struggling with food-reward cravings (carbohydrates, sweets, snacks)
  • Have not tolerated GLP-1 medications due to nausea
  • Have depression or smoking cessation goals (bupropion treats both)

Mysimba is NOT appropriate for patients with: uncontrolled hypertension, history of seizures, eating disorders (especially bulimia or anorexia), severe liver or kidney disease, chronic opioid use, or use of MAOI antidepressants in the previous 14 days.

Every individual’s weight management journey is different. Depending on your health goals, lifestyle preferences, and treatment eligibility, you may wish to explore other weight loss options available. Popular alternatives include GLP-1 treatments such as Wegovy®, Mounjaro®, Biolide® Daily Injection (Liraglutide), and Plaobes® Daily Injection (Liraglutide), as well as capsule-based treatments like Xenical®, Orlos®, and Alli®.

Mysimba Dosing Schedule

Mysimba uses a four-week titration to gradually build up to the maintenance dose:

  • Week 1: 1 tablet in the morning (8 mg naltrexone / 90 mg bupropion)
  • Week 2: 1 tablet morning, 1 evening (16 mg / 180 mg total daily)
  • Week 3: 2 tablets morning, 1 evening (24 mg / 270 mg total daily)
  • Week 4+: 2 tablets morning, 2 evening (32 mg / 360 mg total daily — maintenance)

Take with food but avoid high-fat meals, which significantly increase absorption and side effects. Swallow whole — do not crush, split, or chew.

Side Effects of Mysimba

The most common side effects:

  • Nausea (~32% during titration)
  • Constipation (~19%)
  • Headache (~17%)
  • Insomnia or vivid dreams (~13%) — take morning dose early
  • Dry mouth (~8%)
  • Dizziness or anxiety

Most side effects fade within 4 weeks. If insomnia persists, taking the evening dose earlier (with dinner instead of bedtime) usually helps.

Important warnings:

  • Mysimba can increase blood pressure and heart rate. Your doctor will monitor and may discontinue if uncontrolled hypertension develops.
  • Bupropion lowers seizure threshold. Mysimba is contraindicated if you have a seizure history.
  • Suicidal thoughts and behaviour changes have been reported with bupropion-containing medications. Stop the medication and contact your doctor immediately if you experience worsening mood, anxiety, agitation, or thoughts of self-harm.

Mysimba vs. GLP-1 Medications

Feature Mysimba GLP-1 (Wegovy/Mounjaro)
Form Oral tablet Injection
Frequency Daily Weekly
Average weight loss 5–9% 14.9–20.9%
Mechanism Brain reward + satiety Gut hormone + appetite
Best for Food reward cravings Hunger-driven overeating

Mysimba is less effective on average than GLP-1 medications for total weight loss, but it works through a different mechanism that suits certain patients better — particularly those with strong food reward / cravings as the primary issue rather than physical hunger.

How to Buy Mysimba Online

  1. Complete the free five-minute consultation
  2. Dutch BIG-registered doctor reviews within 24 hours — particular attention to blood pressure, mental health history, seizure risk
  3. Prescription issued if appropriate
  4. IGJ-registered Dutch pharmacy dispenses Mysimba in original packaging
  5. PostNL delivery in 3–5 working days in discreet packaging

Storage

Store Mysimba tablets at room temperature (below 30 °C) in the original blister packaging. No refrigeration required.

Pricing

Mysimba from EU Slim Store starts at €68 per month, all-inclusive: medication, doctor consultation, pharmacy dispensing, and PostNL delivery. Mysimba is our most affordable prescription weight loss treatment.

Get Started

If you’d prefer an oral tablet over an injection, take the free five-minute consultation now. Doctor response within 24 hours.

Informacje dodatkowe

Pack Size

112 Tablets, 224 Tablets

Mysimba FAQs

Mysimba is an oral weight loss tablet combining two medications: naltrexone (an opioid receptor antagonist) and bupropion (a noradrenaline-dopamine reuptake inhibitor). Unlike GLP-1 injections, Mysimba targets the brain's hunger and reward systems directly — reducing both food cravings and appetite. Clinical trials show average weight loss of 5–9% over 56 weeks.

Mysimba is licensed for adults with a BMI ≥ 30, or BMI ≥ 27 with at least one weight-related condition (type 2 diabetes, dyslipidaemia, hypertension). It's particularly suitable for patients who prefer tablets over injections, struggle with food-reward cravings (carbs, sweets), or have not tolerated GLP-1 medications.

Mysimba is a daily oral tablet that targets brain reward and satiety systems — fundamentally different from GLP-1 injections that target gut hormones. Average weight loss is lower (5–9% vs 15–22% for newer GLP-1s) but Mysimba is significantly cheaper, requires no injections, and works particularly well for patients with food-reward cravings.

Mysimba uses 4-week titration: Week 1 = 1 tablet morning. Week 2 = 1 tablet morning + 1 evening. Week 3 = 2 morning + 1 evening. Week 4+ = 2 morning + 2 evening (32 mg naltrexone / 360 mg bupropion daily = maintenance). Take with food but avoid high-fat meals which increase absorption and side effects.

Common side effects: nausea (~32%), constipation (~19%), headache (~17%), insomnia or vivid dreams (~13%), dry mouth, dizziness. Most fade within 4 weeks. If insomnia persists, take the evening dose earlier (with dinner, not bedtime). Mysimba can increase blood pressure and heart rate — your doctor will monitor.

Mysimba is contraindicated in patients with: uncontrolled high blood pressure, seizure history or risk factors, eating disorders (especially bulimia or anorexia), severe liver or kidney disease, chronic opioid use, MAOI antidepressant use in last 14 days, pregnancy or breastfeeding.

Some patients notice reduced food cravings within the first 2 weeks at low doses. Visible weight loss typically begins around weeks 4–8 once you reach the full maintenance dose. Maximum effect is reached at 6–12 months. If you haven't lost at least 5% of body weight after 16 weeks at full dose, your doctor may recommend trying a different treatment.

Mysimba contains bupropion — itself an antidepressant. Combining Mysimba with other antidepressants (especially SSRIs, SNRIs, or MAOIs) requires extreme caution and is often contraindicated. MAOIs must be stopped at least 14 days before starting Mysimba. Disclose all psychiatric medications during your consultation.

Take Mysimba with food but avoid high-fat meals — these can dramatically increase absorption and worsen side effects. A balanced diet focused on lean protein, vegetables, whole grains, and moderate fat works well. Many patients find Mysimba particularly effective for reducing cravings for carbs and sweets.

Store Mysimba tablets at room temperature, below 25 °C, in the original blister packaging. No refrigeration required. Keep out of reach of children. Discard expired medication safely.

If you miss a dose, skip it and resume your normal schedule with the next planned dose. Do not double up to compensate. Doubling can increase seizure risk and side effects significantly. If you've missed multiple doses, contact your doctor — you may need to restart at a lower dose.

Alcohol should be avoided or minimised on Mysimba. Bupropion (a component of Mysimba) lowers seizure threshold, and alcohol — especially binge drinking or sudden cessation after heavy use — significantly increases seizure risk.

Yes — bupropion can rarely cause changes in mood, anxiety, agitation, or in extremely rare cases, suicidal thoughts. Stop the medication and contact your doctor immediately if you experience worsening mood, anxiety, agitation, or thoughts of self-harm. Pre-existing depression, anxiety, or bipolar disorder requires careful evaluation.

Most patients regain some lost weight after stopping Mysimba, especially in the first 6–12 months. Long-term continuation is the standard approach for those who tolerate it well. Bupropion does not typically cause withdrawal symptoms but should be reduced gradually.

Neither is strictly 'safer' — they have different side effect profiles. Mysimba avoids GLP-1 side effects (nausea, gastric emptying issues) but has its own (insomnia, blood pressure increase, seizure risk). GLP-1s have a longer track record. Your doctor will recommend the safest fit based on your medical history.

Reviews

Be the first to review “Mysimba (Naltrexone / Bupropion) Weight Loss Tablets”

Twój adres email nie zostanie opublikowany. Wymagane pola są oznaczone *

There are no reviews yet.

Search

Back to Top

Shipping Address

Product has been added to your cart
Compare (0)